In Photos: Egyptian archaeological mission at Saqqara Necropolis announces new major discoveries    Rare conviction of South Sudan soldiers for rape raises hope    Bahrain's Bank ABC completes $480m acquisition of Blom Bank Egypt    14.7% increase in health expenditures during H1 of FY 2020/21: Maait    Egypt reports 879 new coronavirus cases, 52 deaths on Friday    Talaat Moustafa Group's subsidiary gets approval to develop 5k feddans in Capital Gardens City    LIVE: Egypt v North Macedonia (2021 World Handball Championship)    Uganda's Museveni holds commanding election lead, rival alleges fraud    Ferguson says management all about results, backs Rooney to succeed at Derby    State revenues expected to drop by EGP 150 bln in FY 2020/21 owing to coronavirus    Tennis: Australian Open arrivals hit by 2 COVID positive tests    Retired doctors and more syringes: Biden lays out plan to get America vaccinated    ‘This is not a game': Global virus death toll hits 2 million    Merkel pushes for centrist as party picks new leader    Egypt's Sisi discusses bilateral ties, regional developments with Sudanese delegation    Egypt's Mostaqbal Watan party dominates the leading posts of parliament's 25 committees    Egypt's budget deficit to GDP ratio receded to 3.6% in first half of FY2020/21, revenues rose by 16%    Mubarak-era politician Safwat El-Sherif dies aged 88    Handball: Egypt ease past Chile 35-29 in World Championship opener    Egypt's president, Siemens CEO discuss final deal on construction of electric train system    Hollywood actor Mena Massoud visits Giza pyramids, says is proud of Egyptian culture    Egypt confirms 970 new coronavirus cases, 55 deaths on Tuesday    EgyptAir to operate daily flight to Doha after lifting airspace ban on Qatar    Pound shielded from Covid-19    Egypt reopens airspace and resumes flights with Qatar    Egypt, Tunisia to establish maritime trade route    TVs were high in demand during 2020 on COVID-19 lock down: Samsung    Egypt eyes gradual return for tourism after revenues fall to $4 bln in 2020    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    Coronavirus strikes Egypt's youth team as 17 players, coach test positive    Nassef Sawiris plans to up his stake in owner of New York Knicks, Rangers    Cairo International Book Fair suspended for five months over coronavirus concerns    Egypt unveils largest archaeological discovery in 2020 with over 100 intact sarcophagi    Trump says won't blame Egypt for being ‘upset' over GERD dispute with Ethiopia    Egypt, Ethiopia, Sudan to resume Nile dam talks today    Global Finance: Egypt's Tarek Amer among the world's top 20 central bank governors    The Facebook Preacher's Search for Fame, and Egypt's Economy    Egypt calls on UNSC to address oil spill risks off Yemen coast    Egypt economically strong in face of COVID-19, reforms ongoing: International Cooperation Minister    Arafa Holding reports $144,000 COVID-19-related losses in April    Egypt's efforts in Libya to activate free will of Libyan people: Al-Sisi    Hyksos campaigns were internal takeover, not foreign invaders: study    COVID-19 affects Egypt sporting clubs    COVID-19 will soon turn to seasonal like swine flu: Presidential Health Advisor    ‘Egypt's Support' coalition convenes to discuss its Senate election list    Robbery attempt leads to discovery of Ptolemaic monuments in Qena    Flouting international guidance, Ethiopia unilaterally starts filling its Nile dam    Zaha speaks out after online racial abuse    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Symposium finds type 2 diabetes is a high risk factor for heart disease
Published in Daily News Egypt on 22 - 05 - 2008

CAIRO: The Cairo Cardiovascular Symposium held for medical practitioners highlighted patients with type 2 diabetes mellitus as being at increased risk of having cardiovascular disease (CVD).
According to data quoted from the Centers for Disease Control & Prevention, cardiovascular disease was stressed as the most common and serious complication of diabetes, with heart disease and stroke causing almost 65 percent of all diabetes-related deaths.
Additional risk factors for CVD include obesity, high blood pressure, high cholesterol, physical inactivity and smoking.
The full-day symposium held last week was attended by physicians from across the region, discussing topics such as the high prevalence of diabetes in the Arab region, diabetes as a vascular disease, the cardiovascular risk management approach to diabetes, the dost to health economics approach and the effect of statins in lowering the overall risk of CVD, with interactive case studies on how to apply knowledge in practice.
Addressing the focus of the event, Dr Mourad Abdel Karim Elmourad, consultant and head of the diabetes & endocrinology unit in the Riyadh Medical Complex, said, "This symposium aims to examine the key factors that contribute to the high risk of cardiovascular disease in this region and explore the best long-term solutions to ensure a healthier life as soon as we can.
According to the International Diabetes Federation, the highest prevalence of diabetes among adults aged 20-79 is in the United Arab Emirates, followed by Saudi Arabia (23.7 percent), Bahrain, Kuwait and Oman. Only the South Pacific Island of Nauru has higher levels than this region.
In addition, the fedration said 26 percent of Egyptians have hypertension, compared to 26.3 percent in Kuwait, 32.1 percent in Qatar, 33 percent in Oman and 26.1 percent in Saudi Arabia.
Elaborating on the risk management approach, Professor Peter Lansberg, of the Academic Medical Center in Amesterdam, added: "High cholesterol is another major risk factor for cardiovascular disease and at this symposium we are discussing the benefits of using statins to reduce overall cardiovascular risk. Statins are a class of medications used to lower cholesterol levels in people with or at risk of cardiovascular disease.
In a press release distributed by the symposium organizers, in the US, Lipitor (atorvastatin), one of the statins in the market, is FDA approved to treat adult patients with type 2 diabetes, without clinically evident chronic heart disease but with at least one other risk factor for heart disease such as high blood pressure, smoking or complications of diabetes, including eye disease and protein in urine, to reduce the risk of heart attack and stroke. This is the same in Europe.
In patients with type 2 diabetes without coronary heart disease and at least one other risk factor, the press release continued, Lipitor significantly reduced the risk of major cardiovascular events by 37 percent and the risk of stroke by up to 48 percent.
The event was held in Cairo and speakers included renowned international & regional experts like Professor Helen Colhoun, from the University of Dundee, Scotland, Professor Ben Van Hout of the Julius Center for Health Science and Primary Care, Utrecht University and Pharmerit, and Professor Ramez Guindy of Ein Shams University.


Clic here to read the story from its source.